A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel

<b>Background/Objectives</b>: Triple-negative breast cancer (TNBC) is the most challenging molecular subtype of breast cancer (BC) in clinical practice, associated with a worse prognosis due to limited treatment strategies and its insensitivity to conventional drugs. Zinc is an important trace eleme...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Raiane Aparecida dos Santos Machado, Raoni Pais Siqueira, Fernanda Cardoso da Silva, André Carlos Pereira de Matos, Dayanne Silva Borges, Gislaine Gonçalves Rocha, Thais Cristina Prado de Souza, Rafael Aparecido Carvalho Souza, Clayton Rodrigues de Oliveira, Antônio G. Ferreira, Pedro Ivo da Silva Maia, Victor Marcelo Deflon, Carolina Gonçalves Oliveira, Thaise Gonçalves Araújo
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2024-12-01
Saila:	Pharmaceutics
Gaiak:	Zinc(II) MDA-MB-231 breast cancer chemotherapy
Sarrera elektronikoa:	https://www.mdpi.com/1999-4923/16/12/1610
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!